Entrada Therapeutics, Inc. (TRDA) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Entrada Therapeutics, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -2.96x | 9.83x | -74.60x | -4.47x | -10.45x | -28.22x |
| P/B Ratio | 1.39x | 1.50x | 2.06x | 1.99x | 1.79x | -18.04x |
| P/S Ratio | 16.73x | 3.06x | 3.87x | 0.00x | 0.00x | 0.00x |
| Profitability | ||||||
| Gross Margin | 83.9% | 100.0% | 100.0% | 0.0% | 0.0% | 0.0% |
| Operating Margin | -613.7% | 22.3% | -2.5% | 0.0% | 0.0% | 0.0% |
| Net Margin | -565.5% | 31.1% | -5.2% | 0.0% | 0.0% | 0.0% |
| EBITDA Margin | -560.2% | 24.1% | -0.2% | 0.0% | 0.0% | 0.0% |
| Liquidity | ||||||
| Current Ratio | 12.53x | 11.15x | 2.33x | 9.55x | 44.46x | 11.89x |
| Quick Ratio | 12.53x | 11.15x | 2.33x | 9.55x | 44.46x | 11.89x |
| Leverage | ||||||
| Debt/Equity | 0.17x | 0.14x | 0.28x | 0.12x | 0.00x | 0.00x |
YoY = year-over-year change. Source: FMP..